Interstitial pneumonia with autoimmune features: A critical appraisal of the new definition

Current Opinion in Pulmonary Medicine

Volumn 22, Issue 5, 2016, Pages 442-449

  Strek, Mary E ^a   Costabel, Ulrich ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b RUHRLANDKLINIK   (Germany)

Author keywords

Interstitial lung disease; interstitial pneumonia; interstitial pneumonia with autoimmune features; undifferentiated connective tissue disease

Indexed keywords

AUTOIMMUNITY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DISEASE CLASSIFICATION; HUMAN; INTERSTITIAL PNEUMONIA; MEDICAL TERMINOLOGY; REVIEW; SEROLOGY; AUTOIMMUNE DISEASE; CLASSIFICATION; CLINICAL STUDY; COMPLICATION; IMMUNOLOGY; LUNG DISEASES, INTERSTITIAL;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CLINICAL STUDIES AS TOPIC; CONNECTIVE TISSUE DISEASES; HUMANS; LUNG DISEASES, INTERSTITIAL;

EID: 84977138491     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000298     Document Type: Review

References (35)

1. Travis WD, Costabel U, Hansell DM, et al. An official ATS/ERS statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188:733-748.
2. Kono M, Nakamura Y, Enomoto N, et al. Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One 2014; 9:e94775.
3. Moua T, Zamora AC, Baqir M, et al. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. Respir Res 2014; 15:154.
4. Strand MJ, Sprunger D, Cosgrove GP, et al. Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia. Chest 2014; 146:775-785.
5. Nunes H, Schubel K, Piver D, et al. Nonspecific interstitial pneumonia: survival is influenced by the underlying cause. Eur Respir J 2015; 45:746-755.
6. Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46:976-987.
7. Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia. Am J Respir Crit Care Med 2007; 176:691-697.
8. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999; 17:615-620.
9. Doria A, Mosca M, Gambari PF, et al. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both J Rheumatol 2005; 32:213-215.
10. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease. Chest 2011; 140:1-8.
11. Corte TJ, Copley SJ, Sesai SR, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012; 39:661-668.
12. Fischer A, West SG, Swigris JJ, et al. Connective tissue disease-associated interstitial lung disease. Chest 2010; 138:251-256.
13. Assayag D, Kim EJ, Elicker BM, et al. Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria. Respir Med 2015; 109:1326-1331.
14. Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012; 156:684-691.
15. Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting survival across chronic interstitial lung disease. The ILD-GAP model. Chest 2014; 145:723-728.
16. Kim H-C, Ji W, Kim MY, et al. Interstitial pneumonia related to undifferentiated connective tissue disease. Chest 2015; 147:165-172.
17. Kondoh Y, Johko T, Fukuoka J, et al. Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias. Respir Med 2015; 109:389-396.
18. Ghebre YT, Ragu G. Idiopathic pulmonary fibrosis: novel concepts of proton pump inhibitors as antifibrotic drugs. Am J Respir Crit Care Med 2016; 193:1345-1352.
19. Lee JS, Kim EJ, Lynch KL, et al. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med 2013; 107:249-255.
20. Bauer P, Kalra S, Osborn TG, et al. Influence of autoimmune biomarkers on interstitial lung diseases: a tertiary referral center based case-control study. Respir Med 2015; 109:397-405.
21. Comarmond C, Crestani B, Tazi A, et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Medicine 2014; 93:340-349.
22. Katsumata Y, Kawaguchi Y, Yamanaka H. Interstitial lung disease with ANCAassociated vasculitis. Clin Med Insights 2015; 9:51-56.
23. Ragu G, Collard HR, Eagan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788-824.
24. Walsh SLF, Sverzellati N, Devaraj A, et al. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax 2014; 69:216-222.
25. Collins B, Raghu G. Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened. Eur Respir J 2016; 47:1293-1295.
26. Raghu G, Anstrom KJ, King TE Jr, et al. Prednisone, azathioprine, and Nacetylcysteine for pulmonary fibrosis. N Engl J Med 2012; 366:1968-1977.
27. Ferri C, Manfredi A, Sebastiani M, et al. Interstitial pneumonia with autoimmune features and undifferentiated connective disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 2016; 15:61-70.
28. Oldham JM, Adegunsoye A, Valenzi E, et al. Characterization of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016; 47:1767-1775.
29. Pan L, Liu Y, Sun R, et al. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study. Clin Dev Immunol 2013; 2013:121578.
30. Omote N, Taniguchi H, Kondoh Y, et al. Lung dominant connective tissue disease. Chest 2015; 148:1438-1446.
31. Hu Y, Wang L-S, Wei Y-R, et al. Clinical characteristics of connective tissue disease-associated interstitial lung disease in 1044 Chinese patients. Chest 2016; 149:201-208.
32. Bonella F, Costabel U. Biomarkers in connective tissue disease-associated interstitial lung disease. Semin Respir Crit Care Med 2014; 35:181-200.
33. Fischer A, Lee JS, Cottin V. Interstitial lung disease evaluation: detecting connective tissue disease. Respiration 2015; 90:177-184.
34. Cottin V. Idiopathic interstitial pneumonias with connective tissue diseases features: a review. Respirology 2016; 21:245-258.
35. Chartrand S, Fischer A. Management of connective tissue disease-associated interstitial lung disease. Rheum Dis Clin N Am 2015; 41:279-294.